StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Meanwhile SZLS is trading in a narrow trading zone.

<< Previous

Bullboard Posts

Next >>

Comment by davewhoon Jan 14, 2022 9:37am

111 Views

Post# 34316298

RE:RE:RE:Meanwhile SZLS is trading in a narrow trading zone.

the USA is now racking up 800k new cases a day. The highest in the world. If you look at the world chart covid cases are over 3x higher than the worst time since covid first started building in size in 2020. Latest report I read says half of the population of Europe will have the new variant within just a month time. Are we doing more tests we don't know. Szls will likely shift their priory to Aristotle as soon as they can since it brings in more rev. But the shear numbers of covid cases would indicate to me they must be busy.

COVID Live - Coronavirus Statistics - Worldometer (worldometers.info)

<< Previous

Bullboard Posts

Next >>

AI companies to invest in